Jennifer Horton

ORCID: 0000-0002-9220-4654
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mosquito-borne diseases and control
  • Viral Infections and Vectors
  • Climate Change and Health Impacts
  • Crystallization and Solubility Studies
  • Travel-related health issues
  • X-ray Diffraction in Crystallography
  • COVID-19 epidemiological studies
  • Viral Infections and Outbreaks Research
  • Hepatitis Viruses Studies and Epidemiology
  • Metal complexes synthesis and properties
  • Synthetic Organic Chemistry Methods
  • Healthcare Systems and Reforms
  • Meta-analysis and systematic reviews
  • Organometallic Complex Synthesis and Catalysis
  • Behavioral Health and Interventions
  • Ferrocene Chemistry and Applications
  • Metal-Catalyzed Oxygenation Mechanisms
  • Viral Infections and Immunology Research
  • Global Health Care Issues
  • Polyoxometalates: Synthesis and Applications
  • Pregnancy and Medication Impact
  • Neonatal and fetal brain pathology
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Child Abuse and Trauma

World Health Organization
2024

World Health Organization - Pakistan
2023

Queen's University
2017

Rajarata University of Sri Lanka
2013-2017

University of London
2014

University of Alberta
2009

Stollery Children's Hospital
2009

ABSTRACT From the first isolation of Zika virus (ZIKV) in Uganda 1947, ZIKV had primarily been associated with sporadic human cases Africa and Asia until emerged as an epidemic Americas 2015. As spread into new geographic regions, it now has potential to interact many novel host species whose susceptibility yet be determined. Mathematical models predict a sylvatic reservoir ZIKV, non-human primates (NHPs) likely candidates, though outbreaks areas without NHPs suggest presence other...

10.1101/2025.03.27.645813 preprint EN cc-by-nc bioRxiv (Cold Spring Harbor Laboratory) 2025-03-27

Wild poliovirus type 2 was declared eradicated in September 2015 (1). In April 2016, India, switched from use of trivalent oral vaccine (tOPV; containing types 1, 2, and 3 polio viruses), to bivalent OPV (bOPV; 1 3), as part a globally synchronized initiative withdraw Sabin vaccine. Concurrently, inactivated (IPV) introduced into India's routine immunization program maintain an immunity base that would mitigate the number paralytic cases event epidemic transmission (2,3). After cessation...

10.15585/mmwr.mm6533a5 article EN MMWR Morbidity and Mortality Weekly Report 2016-08-25

Although maternal mortality has become a major focus on global public health agenda, morbidity is neglected area of research. The purpose this paper to present the burden acute illness during pregnancy.

10.1371/journal.pone.0064214 article EN cc-by PLoS ONE 2013-05-10

Even though postpartum morbidity continues to cause high disease burden in maternal and mortality across the globe, literature pertaining resultant productivity loss is scarce. Hence, present study aimed at determining associated cost of episodes ill health.A cross sectional was conducted two Medical Officer Heath areas Anuradhapura district, Sri Lanka 2011, among 407 women residing district with an infant aged between 8 24 weeks. Validated interviewer administered questionnaires, including...

10.1371/journal.pone.0185883 article EN cc-by PLoS ONE 2017-10-11

We have prepared four N-substituted hydroxypyridinones containing alcohol and morpholine groups. Complexes of the type cis-MoO2L2, where L represents hydroxypyridinonato ligands also been synthesized. The ethanolamine derivative, cis-MoO2(hep)2 (5), has characterized by an X-ray diffraction study whereby pyridinone are bound to molybdenum in a cis bidentate fashion via deprotonated hydroxy groups ketone moieties. Crystals (5) triclinic, with 9.1930(7), b 14.2718(8), c 14.6219(9) Å, α...

10.1071/ch00093 article EN Australian Journal of Chemistry 2000-01-01

Abstract Background Yellow fever (YF), a vector-borne viral hemorrhagic fever, is endemic in tropical regions of Africa and South America, with large vaccination programmes being used for control. However, significant outbreaks have occurred recent years. Data on infection rates seroprevalence often sparse, requiring robust mathematical models to estimate the burden yellow fever. In particular, modelling required risk inform policy decisions regarding targeting vaccination. Methods We...

10.1101/2023.12.19.23300139 preprint EN cc-by medRxiv (Cold Spring Harbor Laboratory) 2023-12-19

Condensation of 2-pyridinecarboxaldehydes with 2-, 3-, and 4-H 2 NC 6 H 4 Bpin (pin = 1,2-O C Me ) gave the corresponding boron-containing pyridinecarboxaldimines (N–N ). Addition these ligands to [PtCl (coe)] (coe cis-cyclooctene) complexes type cis-PtCl in moderate yields. The platinum have been examined for their potential cytotoxicities against OV2008 (human ovarian carcinoma) analogous cisplatin-resistant cell line C13. Key words: boronate esters, pyridinecarboxaldimines, cytotoxicity,...

10.1139/v04-147 article EN Canadian Journal of Chemistry 2004-12-01

Yellow fever (YF), a vector-borne viral hemorrhagic fever, is endemic in tropical regions of Africa and South America, with large vaccination programmes being used for control. However, significant outbreaks have occurred recent years. Data on infection rates seroprevalence often sparse, requiring robust mathematical models to estimate the burden yellow fever. In particular, modelling required risk inform policy decisions regarding targeting vaccination. We present dynamic, stochastic model...

10.1371/journal.pgph.0003781 article EN cc-by PLOS Global Public Health 2024-11-13

Background: Yellow fever (YF), a vector-borne viral hemorrhagic fever, is endemic in tropical regions of Africa and South America, with large vaccination programmes being used for control. However, significant outbreaks have occurred recent years. Data on infection rates seroprevalence often sparse, requiring robust mathematical models to estimate the burden yellow fever. In particular, modelling required risk inform policy decisions regarding targeting vaccination. Methods: We present...

10.2139/ssrn.4469377 preprint EN 2023-01-01
Coming Soon ...